Annual EBIT
-$40.44 M
+$1.03 M+2.49%
December 31, 2024
Summary
- As of March 14, 2025, ELEV annual earnings before interest & taxes is -$40.44 million, with the most recent change of +$1.03 million (+2.49%) on December 31, 2024.
- During the last 3 years, ELEV annual EBIT has fallen by -$8.40 million (-26.20%).
- ELEV annual EBIT is now -134.09% below its all-time high of -$17.28 million, reached on December 31, 2020.
Performance
ELEV EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$6.38 M
+$6.85 M+51.77%
December 31, 2024
Summary
- As of March 14, 2025, ELEV quarterly earnings before interest & taxes is -$6.38 million, with the most recent change of +$6.85 million (+51.77%) on December 31, 2024.
- Over the past year, ELEV quarterly EBIT has increased by +$6.85 million (+51.77%).
- ELEV quarterly EBIT is now -225.73% below its all-time high of -$1.96 million, reached on March 31, 2020.
Performance
ELEV Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$40.44 M
+$2.70 M+6.26%
December 31, 2024
Summary
- As of March 14, 2025, ELEV TTM earnings before interest & taxes is -$40.44 million, with the most recent change of +$2.70 million (+6.26%) on December 31, 2024.
- Over the past year, ELEV TTM EBIT has increased by +$2.70 million (+6.26%).
- ELEV TTM EBIT is now -1964.42% below its all-time high of -$1.96 million, reached on March 31, 2020.
Performance
ELEV TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ELEV EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.5% | +51.8% | +6.3% |
| 3 y3 years | -26.2% | +63.6% | +56.8% |
| 5 y5 years | - | +63.6% | +56.8% |
ELEV EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -26.2% | +56.8% | at high | +83.4% | -26.2% | +56.8% |
| 5 y | 5-year | -134.1% | +56.8% | -225.7% | +83.4% | -1964.4% | +56.8% |
| alltime | all time | -134.1% | +56.8% | -225.7% | +83.4% | -1964.4% | +56.8% |
Elevation Oncology EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$40.44 M(-2.5%) | -$6.38 M(-51.8%) | -$40.44 M(-6.3%) |
| Sep 2024 | - | -$13.23 M(+20.7%) | -$43.14 M(+5.7%) |
| Jun 2024 | - | -$10.96 M(+11.1%) | -$40.83 M(+2.8%) |
| Mar 2024 | - | -$9.87 M(+8.7%) | -$39.70 M(-4.3%) |
| Dec 2023 | -$41.47 M(-55.7%) | -$9.08 M(-16.8%) | -$41.47 M(-16.9%) |
| Sep 2023 | - | -$10.92 M(+11.0%) | -$49.94 M(-35.6%) |
| Jun 2023 | - | -$9.83 M(-15.5%) | -$77.55 M(-11.7%) |
| Mar 2023 | - | -$11.64 M(-33.7%) | -$87.83 M(-6.1%) |
| Dec 2022 | -$93.56 M | -$17.54 M(-54.5%) | -$93.56 M(+9.2%) |
| Sep 2022 | - | -$38.53 M(+91.6%) | -$85.64 M(+44.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$20.11 M(+15.8%) | -$59.38 M(+34.0%) |
| Mar 2022 | - | -$17.37 M(+80.5%) | -$44.33 M(+38.3%) |
| Dec 2021 | -$32.05 M(+85.5%) | -$9.62 M(-21.6%) | -$32.05 M(+2.4%) |
| Sep 2021 | - | -$12.28 M(+142.7%) | -$31.31 M(+42.0%) |
| Jun 2021 | - | -$5.06 M(-0.5%) | -$22.04 M(+8.0%) |
| Mar 2021 | - | -$5.09 M(-42.8%) | -$20.40 M(+18.1%) |
| Dec 2020 | -$17.28 M | -$8.89 M(+195.1%) | -$17.28 M(+105.9%) |
| Sep 2020 | - | -$3.01 M(-11.9%) | -$8.39 M(+56.0%) |
| Jun 2020 | - | -$3.42 M(+74.5%) | -$5.38 M(+174.5%) |
| Mar 2020 | - | -$1.96 M | -$1.96 M |
FAQ
- What is Elevation Oncology annual earnings before interest & taxes?
- What is the all time high annual EBIT for Elevation Oncology?
- What is Elevation Oncology annual EBIT year-on-year change?
- What is Elevation Oncology quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Elevation Oncology?
- What is Elevation Oncology quarterly EBIT year-on-year change?
- What is Elevation Oncology TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Elevation Oncology?
- What is Elevation Oncology TTM EBIT year-on-year change?
What is Elevation Oncology annual earnings before interest & taxes?
The current annual EBIT of ELEV is -$40.44 M
What is the all time high annual EBIT for Elevation Oncology?
Elevation Oncology all-time high annual earnings before interest & taxes is -$17.28 M
What is Elevation Oncology annual EBIT year-on-year change?
Over the past year, ELEV annual earnings before interest & taxes has changed by +$1.03 M (+2.49%)
What is Elevation Oncology quarterly earnings before interest & taxes?
The current quarterly EBIT of ELEV is -$6.38 M
What is the all time high quarterly EBIT for Elevation Oncology?
Elevation Oncology all-time high quarterly earnings before interest & taxes is -$1.96 M
What is Elevation Oncology quarterly EBIT year-on-year change?
Over the past year, ELEV quarterly earnings before interest & taxes has changed by +$6.85 M (+51.77%)
What is Elevation Oncology TTM earnings before interest & taxes?
The current TTM EBIT of ELEV is -$40.44 M
What is the all time high TTM EBIT for Elevation Oncology?
Elevation Oncology all-time high TTM earnings before interest & taxes is -$1.96 M
What is Elevation Oncology TTM EBIT year-on-year change?
Over the past year, ELEV TTM earnings before interest & taxes has changed by +$2.70 M (+6.26%)